TY - JOUR
T1 - IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii
AU - Suzuki, Yasuhiro
AU - Sher, Alan
AU - Yap, George
AU - Park, Daniel
AU - Neyer, Lauri Ellis
AU - Liesenfeld, Oliver
AU - Fort, Madeline
AU - Kang, Hoil
AU - Gufwoli, Edgar
PY - 2000/5/15
Y1 - 2000/5/15
N2 - The role for IL-10 in the immunopathogenesis of acute toxoplasmosis following peroral infection was examined in both genetically susceptible C57BL/6 and resistant BALB/c mice. C57BL/6-background IL-10-targeted mutant (IL-10(-/-)) mice all died in 2 wk after infection with 20 cysts of the ME49 strain, whereas only 20% of control mice succumbed. Histological studies revealed necrosis in the small and large intestines and livers of infected IL-10(-/-) mice. The necrosis in the small intestine was the most severe pathologic response and was not observed in control mice. Treatment of infected IL-10(-/-) mice with either anti-CD4 or anti-IFN-γ mAb prevented intestinal pathology and significantly prolonged time to death. Treatment of these animals with anti-IL-12 mAb also prevented the pathology. Significantly greater amounts of IFN-γ mRNA were detected in the lamina propria lymphocytes obtained from the small intestine of infected IL-10(-/-) mice than those from infected control mice. In common with C57BL/6-background IL- 10(-/-) mice, BALB/c-background IL-10(-/-) mice all died developing intestinal pathology after infection. Control BALB/c mice all survived even after infection with 100 cysts and did not develop the intestinal lesions. Treatment with anti-IFN-γ mAb prevented the pathology and prolonged time to death of the infected IL-10(-/-) mice. These results strongly suggest that IL-10 plays a critical role in down-regulating IFN-γ, production in the small intestine following sublethal peroral infection with Toxoplasma gondii and that this down-regulatory effect of IL-10 is required for prevention of development of IFN-γ,-mediated intestinal pathology and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice.
AB - The role for IL-10 in the immunopathogenesis of acute toxoplasmosis following peroral infection was examined in both genetically susceptible C57BL/6 and resistant BALB/c mice. C57BL/6-background IL-10-targeted mutant (IL-10(-/-)) mice all died in 2 wk after infection with 20 cysts of the ME49 strain, whereas only 20% of control mice succumbed. Histological studies revealed necrosis in the small and large intestines and livers of infected IL-10(-/-) mice. The necrosis in the small intestine was the most severe pathologic response and was not observed in control mice. Treatment of infected IL-10(-/-) mice with either anti-CD4 or anti-IFN-γ mAb prevented intestinal pathology and significantly prolonged time to death. Treatment of these animals with anti-IL-12 mAb also prevented the pathology. Significantly greater amounts of IFN-γ mRNA were detected in the lamina propria lymphocytes obtained from the small intestine of infected IL-10(-/-) mice than those from infected control mice. In common with C57BL/6-background IL- 10(-/-) mice, BALB/c-background IL-10(-/-) mice all died developing intestinal pathology after infection. Control BALB/c mice all survived even after infection with 100 cysts and did not develop the intestinal lesions. Treatment with anti-IFN-γ mAb prevented the pathology and prolonged time to death of the infected IL-10(-/-) mice. These results strongly suggest that IL-10 plays a critical role in down-regulating IFN-γ, production in the small intestine following sublethal peroral infection with Toxoplasma gondii and that this down-regulatory effect of IL-10 is required for prevention of development of IFN-γ,-mediated intestinal pathology and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice.
UR - http://www.scopus.com/inward/record.url?scp=0034658617&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034658617&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.164.10.5375
DO - 10.4049/jimmunol.164.10.5375
M3 - Article
C2 - 10799901
AN - SCOPUS:0034658617
SN - 0022-1767
VL - 164
SP - 5375
EP - 5382
JO - Journal of Immunology
JF - Journal of Immunology
IS - 10
ER -